| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.73M | 89.77M | 133.21M | 55.02M | 142.88M | 280.25M |
| Gross Profit | 87.37M | 86.82M | 133.21M | 55.02M | 156.06M | 291.48M |
| EBITDA | 83.79M | 85.53M | 0.00 | 0.00 | 0.00 | 8.00K |
| Net Income | 80.79M | 85.45M | 131.71M | 42.24M | 140.92M | 278.55M |
Balance Sheet | ||||||
| Total Assets | 1.28B | 1.25B | 1.26B | 1.26B | 1.30B | 1.19B |
| Cash, Cash Equivalents and Short-Term Investments | 4.01M | 7.23M | 36.31M | 22.36M | 68.73M | 32.57M |
| Total Debt | 120.00M | 120.00M | 120.00M | 120.00M | 119.87M | 99.62M |
| Total Liabilities | 122.27M | 120.69M | 127.71M | 122.06M | 122.44M | 100.32M |
| Stockholders Equity | 1.16B | 1.13B | 1.14B | 1.14B | 1.18B | 1.09B |
Cash Flow | ||||||
| Free Cash Flow | 36.53M | 69.52M | 150.97M | 37.20M | 80.10M | 56.39M |
| Operating Cash Flow | 36.53M | 69.52M | 150.97M | 37.20M | 80.10M | 56.39M |
| Investing Cash Flow | 27.58M | 0.00 | 0.00 | -2.08M | 35.77M | 0.00 |
| Financing Cash Flow | -105.28M | -98.60M | -137.01M | -83.57M | -43.94M | -67.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | £232.68M | 2.03 | 30.90% | 3.21% | 165.25% | 95.32% | |
76 Outperform | £196.06M | 4.34 | 12.32% | 8.15% | 1.29% | 11.17% | |
76 Outperform | £1.73B | ― | 2.24% | 2.40% | 64.34% | 77.61% | |
75 Outperform | ― | 3.22 | 7.06% | 3.61% | -54.35% | -53.61% | |
70 Outperform | £2.17B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |